| Serial Number | 79307379 |
| Word Mark | ADRESTIA |
| Filing Date | Tuesday, December 8, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 26, 2022 |
| Registration Number | 6709002 |
| Registration Date | Tuesday, April 26, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 8, 2022 |
| Goods and Services | Medical and veterinary preparations for the treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases in humans and animals; pharmaceutical substances and preparations for human use for the diagnosis and treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases; biopharmaceutical substances and preparations for human use for use in the diagnosis and treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases; reagents, diagnostic preparations and therapeutic preparations in the nature of biological, biochemical and chemical reagents and vaccines for medical purposes; biological preparations for medical purposes, for the diagnosis and treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases; medical preparations for use in gene therapy; diagnostic preparations for medical purposes; therapeutic and diagnostic preparations, namely, small molecules for medical use |
| Goods and Services | Chemicals used in science; biological preparations for use in science; biochemicals for research use; cell lines and bio-production cell lines for scientific, laboratory or medical research; reagents, plasmids and assays for scientific, genetic and medical research; molecular biology research tools, in the nature of biological and biochemical reagents; biological and chemical reagents for research use; chemical reagents for scientific and research purposes; proteins in raw material form for scientific and medical research; gene extracts for research purposes; chemicals and biochemicals for drug discovery, lead identification, diagnostics, profiling and research |
| Goods and Services | Medical services; medical and pharmaceutical advisory and consultancy services; preparing pharmaceuticals, namely pharmaceutical compounding services for others; providing personalised medicine services and personalised medical diagnostic reporting services; providing personal medical information; provision of medical information; provision of information to enable human diagnosis of medical conditions; providing medical information to enable healthcare professionals to enable the monitoring of patients; providing medical information to healthcare professionals to enable the assessment of progress in disease and treatment; consultancy and advisory relating to all the aforesaid services |
| Goods and Services | Medical, scientific and industrial research services in the field of cells, cell therapies, genome editing, genetic engineering and gene therapies and targeting therapies to individuals; pharmaceutical and biopharmaceutical research and development services; medical and pharmacological research services; examination and testing of genes for scientific research purposes; development, examination and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, examination and testing of medicaments products; development of test systems for pharmaceutical and biopharmaceutical products; development of databases in the medical, pharmaceutical and biopharmaceutical field; development of gene databases; research and development services in the creation of databases and collections of information on biologicals, genetic material, genetic information, chemicals and compounds for research purposes; providing biological and medical research information; providing scientific research information and data in relation to health and disease state; medical research into personalised medicine; medical research services in the field of personalised diagnostics, medical research services in the field of personal medical profiles; provision of scientific research information in the field of personalised medicine; pharmaceutical drug development services; consultancy and advisory relating to all the aforesaid services |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 26, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 26, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 26, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 26, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Adrestia Therapeutics Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Adrestia Therapeutics Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Adrestia Therapeutics Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Monday, September 26, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, September 2, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, September 2, 2022 | FINAL DISPOSITION PROCESSED |
| Tuesday, July 26, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, May 27, 2022 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Tuesday, April 26, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 8, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 8, 2022 | PUBLISHED FOR OPPOSITION |
| Sunday, February 6, 2022 | NOTIFICATION PROCESSED BY IB |
| Thursday, January 20, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, January 20, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, January 20, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, January 19, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 19, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, January 19, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, January 3, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, December 23, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, December 23, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, December 23, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, December 23, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, December 22, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, December 22, 2021 | FINAL REFUSAL E-MAILED |
| Wednesday, December 22, 2021 | FINAL REFUSAL WRITTEN |
| Tuesday, December 14, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 14, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 14, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, July 11, 2021 | REFUSAL PROCESSED BY IB |
| Monday, June 21, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, June 21, 2021 | REFUSAL PROCESSED BY MPU |
| Saturday, June 12, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, June 11, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, June 7, 2021 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Saturday, May 29, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, May 28, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, May 28, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, March 30, 2021 | APPLICATION FILING RECEIPT MAILED |
| Friday, March 26, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, March 25, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |